Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative methylprednisolone for prevention of postoperative cognitive dysfunction in elderly colorectal cancer surgery patients
ChiCTR-IPR-17013049Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of the University of South China
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone in post-operative cognitive decline (POCD) (2 arms), sponsored by The First Affiliated Hospital of the University of South China. Primary endpoints: Incidence of postoperative cognitive dysfunction, MoCA score and 9 more. Planned start Nov 2017; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR-IPR-17013049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013049.